Wellcome Trust Sanger Institute

The Wellcome Trust Sanger Institute was formed in 1992 for the purposes of funding biomedical research. Specifically genome sequencing efforts. It is the largest charity in the U.K., and receives a majority of its funds from the Wellcome Trust. The Institute is responsible for the completion of the sequencing of approximately 1/3 of the human genome and model genomes of the mouse and zebrafish and more than 90 pathogen genomes. Today, the Wellcome Trust Sanger Institute has been able to attract top scientists and has more than 30 Senior Researchers on staff. The Institute is located in Hinxton, Cambridge, U.K., and spends approximately 650 British Pounds annually to support relevant research by preeminent scientists and labs around the globe. The Institute supports work at the University of Nottingham, MIT, University of Toronto, University of Gothenburg, University of Manchester and other institutions of higher learning research labs.

Address
Hinxton, Cambs, CB10 1SA, UK
Website
http://www.sanger.ac.uk/
Wikipedia
http://en.wikipedia.org/wiki/Wellcome_Trust_Sanger_Institute

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Cancer

CRISPR catches out critical cancer changes

In the first large-scale analysis of cancer gene fusions, which result from the merging of two previously separate genes, researchers at the Wellcome Sanger Institute, EMBL-EBI, Open Targets, GSK and their collaborators have ...

Genetics

Rare genetic change provides clues to pancreas development

Researchers have discovered a key clue into the development of the pancreas and brain by studying rare patients born without a pancreas. The study from the Wellcome Sanger Institute, the University of Exeter and collaborators ...

Genetics

Mice reveal 38 new genes involved in hearing loss

Multiple new genes involved in hearing loss have been revealed in a large study of mouse mutants by researchers from the Wellcome Sanger Institute and King's College London, and colleagues. The new genes identified reveal ...

Cancer

New cancer drug targets accelerate path to precision medicine

In one of the largest studies of its kind, researchers used CRISPR technology to disrupt every gene in over 300 cancer models from 30 cancer types and discover thousands of key genes essential for cancer's survival. The team, ...

Cancer

Major mutation pattern in cancer occurs in bursts

Researchers have created a huge resource for investigating the biological mechanisms that cause cancer. The scientists from the Wellcome Sanger Institute and their collaborators identified which patterns of DNA damage—mutational ...

Immunology

Study reveals how immune cells target different tissues

For the first time, researchers have revealed the different molecular identities of important immune cells, called T regulatory cells, using single cell genomics, in both mouse and human peripheral non-lymphoid tissues such ...

Genetics

GARFIELD classifies disease-relevant changes in the genome

Researchers at the Wellcome Sanger Institute and EMBL's European Bioinformatics Institute (EMBL-EBI) have developed a new approach to understand the functional effects of genetic variations associated with a disease, even ...

page 1 from 25